Literature DB >> 9732316

Alpha-linolenic acid deficiency modifies distractibility but not anxiety and locomotion in rats during aging.

C Belzung1, A M Leguisquet, S Barreau, S Delion-Vancassel, S Chalon, G Durand.   

Abstract

In rodents, chronic dietary alpha-linolenic acid deficiency decreases learning and memory and alters dopaminergic and serotoninergic neurotransmission. However, these two neurotransmitter systems are related mainly to attention, emotion and locomotion. Therefore, we decided to investigate the effects of dietary alpha-linolenic acid deficiency in rats tested with animal models of distractibility (the distractometer procedure), anxiety (the elevated plus maze) and ambulatory activity (a circular corridor). Moreover, because these neurochemical modifications persist during aging, we decided to study the effects of aging on these behaviors by using rats aged 2, 6, 12 and 24 mo. An age-related decline in distractibility was observed that was accelerated by linolenic acid deficiency. Indeed, an age-related reduction in distractibility was found in so far as distraction time was reduced at the age of 12 mo in controls and at the age of 24 mo in deficient groups compared with 2-mo-old rats. Moreover, distraction time was significantly lower in 6- and 24-mo-old rats fed a deficient diet compared with age-matched controls. Anxiety was not modified by diet or age. Finally, a parallel decrease in locomotion was exhibited by rats fed both diets between 6 and 12 mo of age. Locomotion was not modified by diet. These results show that dietary alpha-linolenic deficiency alters behavior in a very specific way; distractibility is modified by diet, whereas anxiety and locomotion are not, suggesting that particular brain areas may be altered.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9732316     DOI: 10.1093/jn/128.9.1537

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  7 in total

1.  Consumption of a high n-3 polyunsaturated fatty acid diet during gradual mild physiological stress in rats.

Authors:  K M Appleton; A J Grippo; T G Beltz; A K Johnson
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2014-12-04       Impact factor: 4.006

2.  EFA supplementation in children with inattention, hyperactivity, and other disruptive behaviors.

Authors:  Laura Stevens; Wen Zhang; Louise Peck; Thomas Kuczek; Nels Grevstad; Anne Mahon; Sydney S Zentall; L Eugene Arnold; John R Burgess
Journal:  Lipids       Date:  2003-10       Impact factor: 1.880

Review 3.  N-3 (omega-3) polyunsaturated Fatty acids in the pathophysiology and treatment of depression: pre-clinical evidence.

Authors:  Beth Levant
Journal:  CNS Neurol Disord Drug Targets       Date:  2013-06       Impact factor: 4.388

4.  Omega-3 polyunsaturated fatty acid (PUFA) status in major depressive disorder with comorbid anxiety disorders.

Authors:  Joanne J Liu; Hanga C Galfalvy; Thomas B Cooper; Maria A Oquendo; Michael F Grunebaum; J John Mann; M Elizabeth Sublette
Journal:  J Clin Psychiatry       Date:  2013-07       Impact factor: 4.384

5.  Jujube promotes learning and memory in a rat model by increasing estrogen levels in the blood and nitric oxide and acetylcholine levels in the brain.

Authors:  Baoli Li; Lu Wang; Yongxian Liu; Yahui Chen; Zhengxiang Zhang; Jing Zhang
Journal:  Exp Ther Med       Date:  2013-04-11       Impact factor: 2.447

6.  Effect of dietary fat type on anxiety-like and depression-like behavior in mice.

Authors:  Wataru Mizunoya; Koichiro Ohnuki; Kento Baba; Hideo Miyahara; Naomi Shimizu; Kuniko Tabata; Takako Kino; Yusuke Sato; Ryuichi Tatsumi; Yoshihide Ikeuchi
Journal:  Springerplus       Date:  2013-04-16

7.  Long-term omega-3 supplementation modulates behavior, hippocampal fatty acid concentration, neuronal progenitor proliferation and central TNF-α expression in 7 month old unchallenged mice.

Authors:  Trent Grundy; Catherine Toben; Emily J Jaehne; Frances Corrigan; Bernhard T Baune
Journal:  Front Cell Neurosci       Date:  2014-11-21       Impact factor: 5.505

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.